Trade Ideas August 12, 2026 05:03 PM

Upgrade to Buy: Lumentum Still Looks Cheap If You Believe the AI Build-Out

Hyperscaler orders, Nvidia commitments, and a manufacturing ramp justify a long-term trade despite lofty multiples.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
LITE

Lumentum (LITE) has been one of 2025-26's biggest winners, but the bull case isn't purely momentum — hyperscaler capex, Nvidia strategic commitments, and a multi-year silicon-photonics bottleneck argue for durable demand. Valuation is rich on headline multiples, yet the market is paying today for a potential oligopoly supplier of high-bandwidth optical interconnects. This trade idea upgrades LITE to a buy with a clearly defined entry, stop and target for a long-term holding period.

Upgrade to Buy: Lumentum Still Looks Cheap If You Believe the AI Build-Out
LITE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Market cap $76.27B; P/E ~152x on EPS $5.63; EV ~$64.5B with FCF $114M.
  • Strategic customer commitments and hyperscaler capex underpin durable demand for optical interconnects.
  • Technical momentum and bullish MACD support a long entry; plan includes entry $900, stop $780, target $1,200.
  • Trade is long-term (180 trading days); valuation is rich so strict risk management is required.

Hook / Thesis

Lumentum has been a poster child of the AI infrastructure rally: the stock has surged dramatically over the past year, yet the company remains central to a near-term shortage in high-speed optical connectivity. Big customers and strategic investments - including public reporting of multi-billion-dollar purchase commitments and a notable Nvidia commitment - make the demand case tangible rather than speculative.

We are upgrading our stance to a buy and field a long-term trade: the combination of durable end-market growth, improving momentum on technicals, and an upcoming manufacturing build-out argue that paying a premium today could still offer attractive absolute upside if Lumentum captures a meaningful share of hyperscaler optical spend. The trade below spells out entry, stop, and targets with a 180-trading-day horizon.

What Lumentum Does and Why the Market Should Care

Lumentum manufactures optical and photonic components, modules and subsystems for Cloud and Networking customers, and sells solid-state and fiber lasers through its Industrial Tech business. Its products sit at the data-center interconnect layer where bandwidth demand is exploding. Hyperscalers and AI chipmakers require high-bandwidth laser sources, coherent optics and silicon-photonics modules to stitch GPUs and accelerators together at scale.

Why this matters: hyperscaler AI investments are large and concentrated. Multiple reports show hyperscalers targeting hundreds of billions in AI infrastructure capex in 2026; the cohort of hyperscalers is projected to spend over $600B on infrastructure with a material portion directed at connectivity and AI-specific hardware. Lumentum is one of a small number of suppliers capable of delivering the optical components at the volumes hyperscalers need, which creates leverage on unit pricing and lead times when demand is tight.

Concrete Financial and Market Signals

Key numbers investors should have front of mind:

  • Market cap: $76.27B.
  • Price / Earnings: ~152x using reported EPS of $5.63.
  • Price / Sales: ~25.66x and EV / Sales ~25.92x.
  • Enterprise value: $64.51B; free cash flow: $114M.
  • Return on equity: 14.74%; debt / equity: 1.10.

Those multiples are elevated on a headline basis. The market is effectively valuing Lumentum as a high-growth, quasi-monopolistic supplier where revenue growth and margin expansion justify today’s price. Operationally, momentum looks constructive: the share sits above its short- and medium-term EMAs (EMA9 $832.97, EMA21 $803.35), 10-day SMA $815.76 and 50-day SMA $816.89, and MACD shows bullish momentum with a positive histogram indicating recent strength.

Valuation Framing

At a $76B market cap and EV of roughly $64.5B, Lumentum trades at stratospheric multiples versus historical hardware peers. But the comparison set is not commodity optics — it's a handful of suppliers to hyperscalers and chipmakers where scarcity and long lead times can produce outsized margins. The company’s EPS of $5.63 implies investors are paying for sustained rapid growth over many years. That’s a high bar and explains why multiples look rich today; the investment thesis relies on market share wins and continued capacity-tight conditions rather than multiple expansion alone.

Put differently: the stock is priced for success. Our upgrade reflects a view that the success scenario is more likely than markets previously expected thanks to recent customer commitments, but the premium requires active risk management (see trade plan).

Catalysts to Monitor

  • Hyperscaler order flow and public comments about optical supply constraints - any incremental large purchase orders would be a direct revenue print driver.
  • Nvidia’s investments and purchase commitments disclosed in June 2026; further strategic announcements or engineering collaborations would increase visibility.
  • Operational ramp at the new North Carolina manufacturing facility expected to scale capacity by mid-2028 - earlier-than-expected throughput gains would accelerate revenue capture.
  • Quarterly results showing sequential margin expansion or beat-and-raise guidance on bookings and backlog.
  • Macro liquidity and interest-rate backdrop - softer equity markets or a risk-off move would likely compress multiples and pressure the stock despite fundamentals.

Trade Plan (Actionable)

Thesis: Buy LITE for capture of the next phase of data-center optical spend as hyperscalers increase AI infrastructure build-out. This is a momentum-plus-fundamentals trade: we want exposure but with defined downside protection.

Element Detail
Trade direction Long
Entry $900.00
Stop loss $780.00 (hard stop)
Target $1,200.00
Horizon Long term (180 trading days) - allow time for order absorption, capacity ramps, and at least two quarterly prints.
Position sizing Size as a measured allocation given valuation risk; consider 2-4% of portfolio on a full-size entry with trailing risk management.

Rationale for levels: $900 is just under the current intraday range and provides a small buffer from one-day volatility; $780 sits below recent corrective support levels and protects against a high-multiple unwind; $1,200 is reachable if Lumentum continues to convert large purchase commitments into revenue and the market re-rates optics suppliers with stronger-than-expected margins.

Risks and Counterarguments

We lay out the principal risks below and one clear counterargument to our upgrade:

  • Valuation vulnerability. The company trades at ~152x earnings and EV/S >25x; any slowdown in orders or margin misses will trigger steep multiple contraction.
  • Customer concentration and execution. A large portion of future demand is tied to a handful of hyperscalers and strategic partners. If one large customer reduces commitments or pushes timelines, revenue growth and pricing power could take a hit.
  • Manufacturing ramp risk. The thesis assumes North Carolina capacity comes online and ramps as expected by mid-2028. Delays, yield problems, or cost overruns would impair revenue capture and push out margin expansion.
  • Macro / liquidity shock. Rising interest rates or a broad tech sell-off could compress multiples irrespective of Lumentum’s fundamentals; the stock’s high multiple makes it particularly sensitive to risk-off moves.
  • Competition and technology risk. Competitors or alternative architectures (different optical technologies or integrated silicon-photonics advances) could erode pricing power or market share.

Counterargument: Critics will point to the thin margin of safety in the valuation and argue the market is priced for near-perfect execution. That is a fair critique. If you believe alternative suppliers will scale quickly or hyperscalers will vertically integrate, this thesis weakens materially. The trade is therefore conditional: it is a buy only if you accept the operational-risk-for-reward tradeoff and manage downside with a strict stop.

Conclusion - What Would Change My Mind

I am upgrading Lumentum to a buy because the company sits at a choke-point in AI data-center infrastructure where demand and strategic customer commitments materially raise the probability of multi-year growth. The technical backdrop is constructive and several tangible catalysts could convert expectations into revenue and cash flow upside.

What would change my mind to a sell or neutral? A combination of (1) a publicly disclosed cancellation or significant delay of a large hyperscaler order, (2) a missed quarter showing weaker-than-expected backlog conversion or margin contraction, or (3) a failed manufacturing ramp with clear yield or capital-overrun problems. Any of those would undermine the core revenue-capture argument and justify exiting above our stop.

Key takeaway: Lumentum is priced for perfection but positioned for it. If you want exposure to the next phase of AI infrastructure and can accept elevated valuation risk, buy on a disciplined plan with a $780 stop and a $1,200 target over the next 180 trading days.

Risks

  • High valuation: P/E ~152x and EV/S >25x leaves limited room for earnings or revenue misses.
  • Customer concentration: heavy reliance on a small number of hyperscalers and strategic partners.
  • Manufacturing execution risk: delays or yield issues at the new North Carolina facility would push out revenue capture.
  • Macro/market risk: a tech sell-off or rising rates could sharply compress multiples regardless of fundamentals.

More from Trade Ideas

Engine Room Momentum: Why I'm Adding GE Aerospace on the Backlog and Production Ramp Aug 12, 2026 Consumers Bancorp (CBKM): A Clean-Running Micro-Cap Bank — Tactical Long Setup Aug 12, 2026 ADMA Biologics: Earnings Reset Creates a Risk-Adjusted Entry Near $10 Aug 12, 2026 Buy Definium Ahead of September Catalyst — High Reward If DT120 Readout Confirms Two-Indication Signal Aug 12, 2026 Caledonia Mining: Q2 Momentum Is Real, But Zimbabwe Risk Keeps This a Tactical Long Aug 12, 2026